Conditions & Recovery · NCI Cancer Currents Blog · August 6, 2026

Could Functional Precision Medicine Be the New Precision Oncology?

Functional precision medicine tests drugs directly on living tumor cells to help clinicians identify the most effective, personalized treatments for their patients. NCI Director Dr. Anthony Letai shares his personal journey with the technology and highlights next steps for advancing the field from a recent NCI workshop.

Originally published by NCI Cancer Currents Blog. We curate and add context; they did the reporting.

Read the full story at NCI Cancer Currents Blog ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor